Cheolwon Suh


Ontology type: schema:Person     


Person Info

NAME

Cheolwon

SURNAME

Suh

Publications in SciGraph latest 50 shown

  • 2019-01 Venous thromboembolism in relapsed or refractory multiple myeloma patients treated with lenalidomide plus dexamethasone in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2018-12 The cell-of-origin classification of diffuse large B cell lymphoma in a Korean population by the Lymph2Cx assay and its correlation with immunohistochemical algorithms in ANNALS OF HEMATOLOGY
  • 2018-10 Phase I study of CKD-581, a pan-histone deacetylase inhibitor, in patients with lymphoma or multiple myeloma refractory to standard therapy in INVESTIGATIONAL NEW DRUGS
  • 2018-10 Treating synchronous bilateral ocular adnexal marginal zone lymphoma: the consortium for improving survival of lymphoma study in ANNALS OF HEMATOLOGY
  • 2018-08 Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a multicenter retrospective analysis in ANNALS OF HEMATOLOGY
  • 2018-04 Lymphoma epidemiology in Korea and the real clinical field including the Consortium for Improving Survival of Lymphoma (CISL) trial in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2017-11 PD-L1 expression correlates with VEGF and microvessel density in patients with uniformly treated classical Hodgkin lymphoma in ANNALS OF HEMATOLOGY
  • 2017-09 Interim 18F-FGD PET/CT may not predict the outcome in primary central nervous system lymphoma patients treated with sequential treatment with methotrexate and cytarabine in ANNALS OF HEMATOLOGY
  • 2016-08 A new extranodal scoring system based on the prognostically relevant extranodal sites in diffuse large B-cell lymphoma, not otherwise specified treated with chemoimmunotherapy in ANNALS OF HEMATOLOGY
  • 2016-06 Programmed death 1 expression in the peritumoral microenvironment is associated with a poorer prognosis in classical Hodgkin lymphoma in TUMOR BIOLOGY
  • 2016-04 Pretreatment whole blood Epstein-Barr virus-DNA is a significant prognostic marker in patients with Hodgkin lymphoma in ANNALS OF HEMATOLOGY
  • 2016-03 Prognostic factors for re-mobilization using plerixafor and granulocyte colony-stimulating factor (G-CSF) in patients with malignant lymphoma or multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy: the Korean multicenter retrospective study in ANNALS OF HEMATOLOGY
  • 2015-11 Salvage chemotherapy of gemcitabine, dexamethasone, and cisplatin (GDP) for patients with relapsed or refractory peripheral T-cell lymphomas: a consortium for improving survival of lymphoma (CISL) trial in ANNALS OF HEMATOLOGY
  • 2015-10 Is there role of additional chemotherapy after definitive local treatment for stage I/II marginal zone lymphoma?: Consortium for Improving Survival of Lymphoma (CISL) study in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2015-10 Body mass index as a prognostic factor in Asian patients treated with chemoimmunotherapy for diffuse large B cell lymphoma, not otherwise specified in ANNALS OF HEMATOLOGY
  • 2014-11 Concurrent chemoradiotherapy followed by l-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK/T cell lymphoma: CISL08-01 phase II study in ANNALS OF HEMATOLOGY
  • 2014-10 The highest prognostic impact of LDH among International Prognostic Indices (IPIs): an explorative study of five IPI factors among patients with DLBCL in the era of rituximab in ANNALS OF HEMATOLOGY
  • 2014-10 LGALS3 as a prognostic factor for classical Hodgkin’s lymphoma in MODERN PATHOLOGY
  • 2014-09 Health-related quality of life in Korean lymphoma survivors compared with the general population in ANNALS OF HEMATOLOGY
  • 2014-08 Chromosome 13 deletion and hypodiploidy on conventional cytogenetics are robust prognostic factors in Korean multiple myeloma patients: web-based multicenter registry study in ANNALS OF HEMATOLOGY
  • 2014-06 Prognostic impact of beta-2 microglobulin in patients with extranodal natural killer/T cell lymphoma in ANNALS OF HEMATOLOGY
  • 2014-03 Clinical significance of the appearance of abnormal protein band in patients with multiple myeloma in ANNALS OF HEMATOLOGY
  • 2014-01 Lenalidomide with dexamethasone treatment for relapsed/refractory myeloma patients in Korea—experience from 110 patients in ANNALS OF HEMATOLOGY
  • 2013-12 Changing trend of Epstein-Barr virus association in Hodgkin lymphoma in the Republic of Korea in ANNALS OF HEMATOLOGY
  • 2013-12 Clinical significance of cytogenetic aberrations in bone marrow of patients with diffuse large B-cell lymphoma: prognostic significance and relevance to histologic involvement in JOURNAL OF HEMATOLOGY & ONCOLOGY
  • 2013-12 Extranodal natural killer/T-cell lymphoma involving the gastrointestinal tract: analysis of clinical features and outcomes from the Asia Lymphoma study group in JOURNAL OF HEMATOLOGY & ONCOLOGY
  • 2013-12 A phase I study of everolimus and CHOP in newly diagnosed peripheral T-cell lymphomas in INVESTIGATIONAL NEW DRUGS
  • 2013-12 18F-FDG PET in Patients with Primary Systemic Anaplastic Large Cell Lymphoma: Differential Features According to Expression of Anaplastic Lymphoma Kinase in NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2013-10 The role of 18F-fluorodeoxyglucose positron emission tomography at response assessment after autologous stem cell transplantation in T-cell non-Hodgkin’s lymphoma patients in ANNALS OF HEMATOLOGY
  • 2013-09 MET and MST1R as prognostic factors for classical Hodgkin’s lymphoma in MODERN PATHOLOGY
  • 2013-04 Repeated radioimmunotherapy with 131I-rituximab for patients with low-grade and aggressive relapsed or refractory B cell non-Hodgkin lymphoma in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2013-03 Matched-pair analysis to compare the outcomes of a second salvage auto-SCT to systemic chemotherapy alone in patients with multiple myeloma who relapsed after front-line auto-SCT in BONE MARROW TRANSPLANTATION
  • 2013-03 Blastic plasmacytoid dendritic cell neoplasm: a single-center experience in ANNALS OF HEMATOLOGY
  • 2013-02 Point prevalence of Pneumocystis pneumonia in patients with non-Hodgkin lymphoma according to the number of cycles of R-CHOP chemotherapy in ANNALS OF HEMATOLOGY
  • 2013-02 High-dose chemotherapy and autologous stem-cell transplantation in Korean patients with relapsed or refractory Hodgkin lymphoma in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2013-02 Prognostic implications of tumor extent in early-stage diffuse large B-cell lymphoma in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2012-12 A unique pattern of extranodal involvement in Korean adults with sporadic Burkitt lymphoma: a single center experience in ANNALS OF HEMATOLOGY
  • 2012-12 Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL) in JOURNAL OF HEMATOLOGY & ONCOLOGY
  • 2012-11 Waldeyer’s ring marginal zone B cell lymphoma: are the clinical and prognostic features nodal or extranodal? A study by the Consortium for Improving Survival of Lymphoma (CISL) in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2012-11 The comparison between CHOP and R-CHOP in primary gastric diffuse large B cell lymphoma in ANNALS OF HEMATOLOGY
  • 2012-09 Impact of the Epstein–Barr virus positivity on Hodgkin's lymphoma in a large cohort from a single institute in Korea in ANNALS OF HEMATOLOGY
  • 2012-07 The role of prophylactic antimicrobials during autologous stem cell transplantation: a single-center experience in EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
  • 2012-06 Phase II study of pemetrexed plus oxaliplatin for platinum-resistant advanced or metastatic non-small cell lung cancer patients in MEDICAL ONCOLOGY
  • 2012-04 Phase II trial of rituximab plus CVP combination chemotherapy for advanced stage marginal zone lymphoma as a first-line therapy: Consortium for Improving Survival of Lymphoma (CISL) study in ANNALS OF HEMATOLOGY
  • 2012-02 Clinical features and outcomes of Hodgkin’s lymphoma in Korea: Consortium for Improving Survival of Lymphoma (CISL) in ANNALS OF HEMATOLOGY
  • 2012-02 Dose modification of alemtuzumab in combination with dexamethasone, cytarabine, and cisplatin in patients with relapsed or refractory peripheral T-cell lymphoma: analysis of efficacy and toxicity in INVESTIGATIONAL NEW DRUGS
  • 2012-02 Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial in ANNALS OF HEMATOLOGY
  • 2011-12 Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL) in BMC CANCER
  • 2011-10 Expression of JL1 in Burkitt lymphoma is associated with improved overall survival in VIRCHOWS ARCHIV
  • 2011-10 Fatal interstitial pneumonitis in a patient with relapsed diffuse large B cell lymphoma following yttrium-90 ibritumomab tiuxetan in INVESTIGATIONAL NEW DRUGS
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.413967.e", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.264381.a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.256681.e", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.255166.3", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412484.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411982.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.470171.4", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.31501.36", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.15444.30", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411653.4", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.254224.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.222754.4", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411277.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411261.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.267370.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.410914.9", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.256753.0", 
            "type": "Organization"
          }
        ], 
        "familyName": "Suh", 
        "givenName": "Cheolwon", 
        "id": "sg:person.016433344622.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016433344622.44"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T14:24", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_2159.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.016433344622.44'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.016433344622.44'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.016433344622.44'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.016433344622.44'


     

    This table displays all metadata directly associated to this object as RDF triples.

    48 TRIPLES      10 PREDICATES      27 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.016433344622.44 schema:affiliation Na8ec7e45f2654c9282915deea47b9cfe
    2 https://www.grid.ac/institutes/grid.15444.30
    3 https://www.grid.ac/institutes/grid.222754.4
    4 https://www.grid.ac/institutes/grid.254224.7
    5 https://www.grid.ac/institutes/grid.255166.3
    6 https://www.grid.ac/institutes/grid.256681.e
    7 https://www.grid.ac/institutes/grid.256753.0
    8 https://www.grid.ac/institutes/grid.264381.a
    9 https://www.grid.ac/institutes/grid.267370.7
    10 https://www.grid.ac/institutes/grid.31501.36
    11 https://www.grid.ac/institutes/grid.410914.9
    12 https://www.grid.ac/institutes/grid.411261.1
    13 https://www.grid.ac/institutes/grid.411277.6
    14 https://www.grid.ac/institutes/grid.411653.4
    15 https://www.grid.ac/institutes/grid.411982.7
    16 https://www.grid.ac/institutes/grid.412484.f
    17 https://www.grid.ac/institutes/grid.470171.4
    18 schema:familyName Suh
    19 schema:givenName Cheolwon
    20 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016433344622.44
    21 schema:sdDatePublished 2019-03-07T14:24
    22 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    23 schema:sdPublisher N2a097b7d35c24f0685e9310f6eaa326e
    24 sgo:license sg:explorer/license/
    25 sgo:sdDataset persons
    26 rdf:type schema:Person
    27 N2a097b7d35c24f0685e9310f6eaa326e schema:name Springer Nature - SN SciGraph project
    28 rdf:type schema:Organization
    29 Na8ec7e45f2654c9282915deea47b9cfe schema:affiliation https://www.grid.ac/institutes/grid.413967.e
    30 sgo:isCurrent true
    31 rdf:type schema:OrganizationRole
    32 https://www.grid.ac/institutes/grid.15444.30 schema:Organization
    33 https://www.grid.ac/institutes/grid.222754.4 schema:Organization
    34 https://www.grid.ac/institutes/grid.254224.7 schema:Organization
    35 https://www.grid.ac/institutes/grid.255166.3 schema:Organization
    36 https://www.grid.ac/institutes/grid.256681.e schema:Organization
    37 https://www.grid.ac/institutes/grid.256753.0 schema:Organization
    38 https://www.grid.ac/institutes/grid.264381.a schema:Organization
    39 https://www.grid.ac/institutes/grid.267370.7 schema:Organization
    40 https://www.grid.ac/institutes/grid.31501.36 schema:Organization
    41 https://www.grid.ac/institutes/grid.410914.9 schema:Organization
    42 https://www.grid.ac/institutes/grid.411261.1 schema:Organization
    43 https://www.grid.ac/institutes/grid.411277.6 schema:Organization
    44 https://www.grid.ac/institutes/grid.411653.4 schema:Organization
    45 https://www.grid.ac/institutes/grid.411982.7 schema:Organization
    46 https://www.grid.ac/institutes/grid.412484.f schema:Organization
    47 https://www.grid.ac/institutes/grid.413967.e schema:Organization
    48 https://www.grid.ac/institutes/grid.470171.4 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...